↓ Skip to main content

Publications

Papers are listed from PubMed IDs and DOIs. Title, authors, journal, and links are fetched from PubMed and Crossref when the site is built.

2024

  1. The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

    Malta TM, Sabedot TS, Morosini NS, Datta I, Garofano L, Vallentgoed W, …, Iavarone A, Noushmehr H

    Cancer Res 2024;84(5):741-756

2023

  1. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting

    Rautajoki KJ, Jaatinen S, Hartewig A, Tiihonen AM, Annala M, Salonen I, …, Haapasalo H, Nykter M

    Acta Neuropathologica Communications 2023;11(1)

  2. Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells

    Fabro F, Kers TV, Feller KJ, Beerens C, Ntafoulis I, Idbaih A, …, Lamfers MLM, Leenstra S

    International Journal of Molecular Sciences 2023;24(21):15678

  3. Identifying predictors of glioma evolution from longitudinal sequencing

    Mu Q, Chai R, Pang B, Yang Y, Liu H, Zhao Z, …, Jiang T, Wang J

    Sci Transl Med 2023;15(716):eadh4181

  4. Spatially resolved transcriptomic profiles reveal unique defining molecular features of infiltrative 5ALA-metabolizing cells associated with glioblastoma recurrence

    Andrieux G, Das T, Griffin M, Straehle J, Paine SML, Beck J, …, Rahman R, Chakraborty S

    Genome Medicine 2023;15(1)

2022

  1. Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma

    Wu L, Wu W, Zhang J, Zhao Z, Li L, Zhu M, …, Jiang T, Wang Q

    Cancer Discov 2022;12(12):2820-2837

  2. Glioma progression is shaped by genetic evolution and microenvironment interactions

    Varn FS, Johnson KC, Martinek J, Huse JT, Nasrallah MP, Wesseling P, …, Verhaak RGW, GLASS Consortium

    Cell 2022;185(12):2184-2199.e16

  3. Global DNA methylation profiling reveals chromosomal instability in IDH-mutant astrocytomas

    Liu Y, Sathe AA, Abdullah KG, McBrayer SK, Adams SH, Brenner AJ, …, Walker JM, Richardson TE

    Acta Neuropathologica Communications 2022;10(1)

2021

  1. Radiotherapy is associated with a deletion signature that contributes to poor outcomes in patients with cancer

    Kocakavuk E, Anderson KJ, Varn FS, Johnson KC, Amin SB, Sulman EP, …, Barthel FP, Verhaak RGW

    Nat Genet 2021;53(7):1088-1096

  2. Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities

    Garofano L, Migliozzi S, Oh YT, D'Angelo F, Najac RD, Ko A, …, Lasorella A, Iavarone A

    Nat Cancer 2021;2(2):141-156

  3. Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

    Gromeier M, Brown MC, Zhang G, Lin X, Chen Y, Wei Z, …, Bigner DD, Ashley DM

    Nat Commun 2021;12(1):352

2020

  1. iGLASS: imaging integration into the Glioma Longitudinal Analysis Consortium

    Bakas S, Ormond DR, Alfaro-Munoz KD, Smits M, Cooper LAD, Verhaak R, Poisson LM

    Neuro Oncol 2020;22(10):1545-1546

  2. The Magnifying GLASS: Longitudinal Analysis of Adult Diffuse Gliomas

    Narayanan A, Turcan S

    Cell 2020;180(3):407-409

2019

  1. Longitudinal molecular trajectories of diffuse glioma in adults

    Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E, …, Verhaak RGW, GLASS Consortium

    Nature 2019;576(7785):112-120

2018

  1. Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium

    GLASS Consortium

    Neuro Oncol 2018;20(7):873-884